North America Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

Published by: Global Markets Direct

Published: Sep. 28, 2009 - 93 Pages

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

3 Definitions of Markets Covered in This Report

3.1 Drug delivery devices

3.2 Needle-free Injections

3.3 Inhalation Systems

3.4 Infusion Systems

4 Drug Delivery Devices in North America

4.1 Drug Delivery Devices, North America, Overall Revenue ($ mn), 2000-2015

4.2 Drug Delivery Devices, North America, Category Volume (Units), 2000-2015

4.3 Drug Delivery Devices, North America, Company Share (2007-2008)

5 Drug Delivery Devices In United States

5.1 Drug Delivery Devices, United States, Overall Revenue ($ mn), 2000-2015

5.2 Drug Delivery Devices, United States, Category Volume (Units), 2000-2015

5.3 Drug Delivery Devices, United States, Distribution Share (2007-2008)

5.3.1 Infusion Systems Distribution Share (2007-2008)

5.3.2 Inhalation Systems Distribution Share (2007-2008)

5.3.3 Needle Free Injections Distribution Share (2007-2008)

5.4 Drug Delivery Devices, United States, Company Share (2007-2008)

5.4.1 Drug Delivery Devices, United States, Company Share (2007-2008)

5.4.2 Infusion Systems, United States, Company Share (2007-2008)

5.4.3 Inhalation Systems, United States, Company Share (2007-2008)

5.4.4 Needle Free Injections, United States, Company Share (2007-2008)

6 Drug Delivery Devices In Canada

6.1 Drug Delivery Devices, Canada, Overall Revenue ($ mn), 2000-2015

6.2 Drug Delivery Devices, Canada, Category Volume (Units), 2000-2015

6.3 Drug Delivery Devices, Canada, Distribution Share (2007-2008)

6.3.1 Infusion Systems Distribution Share (2007-2008)

6.3.2 Inhalation Systems Distribution Share (2007-2008)

6.3.3 Needle Free Injections Distribution Share (2007-2008)

6.4 Drug Delivery Devices, Canada, Company Share (2007-2008)

6.4.1 Drug Delivery Devices, Canada, Company Share (2007-2008)

6.4.2 Infusion Systems, Canada, Company Share (2007-2008)

6.4.3 Inhalation Systems, Canada, Company Share (2007-2008)

6.4.4 Needle Free Injections, Canada, Company Share (2007-2008)

7 Overview of Key Companies in North America Drug Delivery Devices Market

7.1 AstraZeneca PLC

7.1.1 Company Overview

7.2 Sepracor Inc.

7.2.1 Company Overview

7.3 Antares Pharma, Inc.

7.3.1 Company Overview

7.4 Boehringer Ingelheim GmbH

7.4.1 Company Overview

7.5 Baxter International Inc.

7.5.1 Company Overview

7.6 Novartis AG

7.6.1 Company Overview

7.7 Terumo Corporation

7.7.1 Company Overview

7.7.2 Terumo Corporation Pipeline Products

7.7.2.1 Terumo Corporation Pipeline Products By Equipment Type

7.7.2.2 Terumo Corporation Pipeline Products By Development Stage

7.7.2.3 Terumo Corporation Pipeline Products By Therapy Area

7.7.2.4 Terumo Corporation Pipeline Products By Clinical Trials

7.7.2.5 Terumo Corporation Pipeline Products By News Summary

7.8 Cardinal Health, Inc.

7.8.1 Company Overview

7.9 GlaxoSmithKline plc

7.9.1 Company Overview

7.10 B. Braun Melsungen AG

7.10.1 Company Overview

7.11 Smiths Medical

7.11.1 Company Overview

7.12 Fresenius Kabi AG

7.12.1 Company Overview

7.13 Bioject Medical Technologies Inc.

7.13.1 Company Overview

7.13.2 Bioject Medical Technologies Inc. Pipeline Products

7.13.2.1 Bioject Medical Technologies Inc. Pipeline Products By Equipment Type

7.13.2.2 Bioject Medical Technologies Inc. Pipeline Products By Development Stage

7.13.2.3 Bioject Medical Technologies Inc. Pipeline Products By Therapy Area

7.13.2.4 Bioject Medical Technologies Inc. Pipeline Products By Clinical Trials

7.13.2.5 Bioject Medical Technologies Inc. Pipeline Products By News Summary

7.14 Consort Medical plc

7.14.1 Company Overview

7.14.2 Consort Medical plc Pipeline Products

7.14.2.1 Bespak plc Pipeline Products By Equipment Type

7.14.2.2 Bespak plc Pipeline Products By Development Stage

7.14.2.3 Bespak plc Pipeline Products By Therapy Area

7.15 Hospira, Inc.

8 Financial Deals Landscape

8.1 Merger

8.1.1 BBV Vietnam S.E.A. Acquisition To Merge With Migami

8.2 Acquisition

8.2.1 Dainippon Sumitomo Pharma To Acquire Sepracor For $2.6 Billion

8.2.2 Hisamitsu Pharmaceutical Completes Acquisition Of Noven Pharmaceuticals

8.2.3 Teikoku Pharma USA Acquires Travanti Pharma

8.2.4 Baxter International Completes Acquisition Of 40% Interest In SIGMA International General Medical Apparatus

8.2.5 Endo Pharmaceuticals Acquires Indevus Pharmaceuticals

8.3 Partnerships

8.3.1 Endo Pharmaceuticals Signs Licensing Agreement With ProStrakan Group

8.3.2 BioChemics Signs An Agreement With Pacific Pharmaceutical

8.3.3 Patton Medical Devices Enters Into Agreement With Unomedical

8.3.4 Baxter International Enters Into A Distribution Agreement With SIGMA International

8.3.5 Altea Therapeutics Enters Into An Agreement With Eli Lily And Amylin Pharmaceuticals

8.3.6 FluGen Enters Into An Agreement With Ratio

8.3.7 MDRNA Enters Into An Agreement With Novartis

8.3.8 DSM Biomedical Enters Into An Agreement With MediVas

9 Recent Developments

9.1 Strategy and Business Planning

9.1.1 Sep 02, 2009: Generex Launches European Subsidiary

9.1.2 Jul 10, 2009: Cardinal Health Board Approves CareFusion Spinoff

9.1.3 May 18, 2009: MEI And GE Healthcare Sign Strategic Agreement

9.1.4 Mar 24, 2009: Hospira Announces Plans To Optimize Operations, Increase Shareholder Value

9.2 Legal and Regulatory

9.2.1 Aug 27, 2009: Court Denies Covidien Subsidiary's Patent Law Suit

9.2.2 Jul 29, 2009: Kendall Law Group Files Class Action Suit Against Genzyme

9.2.3 May 27, 2009: Verus Pharmaceuticals Files Lawsuit Against AstraZeneca and Tika

9.2.4 May 21, 2009: QLT Announces Court Response To Motion To Dismiss And Removal Of Case To Federal Court

9.2.5 May 18, 2009: Corium Fentanyl Patch Plant Is Slapped With A Form 483

9.2.6 Apr 07, 2009: Mallinckrodt Sues Two Bracco Units Over Patent-Infringement

9.2.7 Mar 11, 2009: Akela Pharma Announces Settlement Agreement In Lab Research Litigation

9.3 Government and Public Interest

9.3.1 Jul 29, 2009: Drug Delivery Via Prototype Contact Lenses

9.3.2 Mar 10, 2009: Risk Of Burns During MRI Scans From Transdermal Drug Patches With Metallic Backings

9.4 Product News

9.4.1 Jun 25, 2009: Maximus Presents MaxPlus Clear At Infusion Nursing Society Annual Conference

9.4.2 Jun 09, 2009: Greyson International Announces Safety Study Results Of Trilexon System

9.4.3 Jun 08, 2009: Delcath Systems Completes Seventy Five Percent Patient Enrollment In Pivotal Phase III Metastatic Melanoma Clinical Trial

9.4.4 Jun 08, 2009: MannKind Initiates Development Of Next-Generation Inhalation System To Enhance Delivery Of Drug Powders

9.4.5 Apr 21, 2009: Greyson Announces Trademark Approval For Trilexon System

9.4.6 Apr 17, 2009: Optinose Presents New Data Of Nasal Drug Delivery Device With fluticasone For The Treatment Of Chronic Rhinosinusitis

9.4.7 Apr 10, 2009: Delcath Announces Expansion Of Clinical Trial Centers To Test PHP System

9.4.8 Apr 04, 2009: Bioject Medical Technologies Receives US FDA Approval To Market Zetajet Needle-Free Injection Therapy System

9.4.9 Mar 23, 2009: DSMB Recommends Continuation Of Phase III Study Testing Delcath's PHP System

9.4.10 Mar 10, 2009: Vyteris Announces Phase II Clinical Trial Commencement Of Smart Patch Technology For Infertility Treatment

9.4.11 Jan 19, 2009: AeonClad Biomedical Utilizes AeonCoat Technology To the Drug Delivery And Medical Devices Markets

9.4.12 Jan 15, 2009: Teva Specialty Pharmaceuticals Donates ProAir HFA To Direct Relief International Help Economically Disadvantaged Asthma Sufferers Breathe Easier

9.4.13 Jan 08, 2009: Medegen Announces 510(k) Clearance For MaxGuard Advanced Luer-Activated Device With Antimicrobial Technology

10 Appendix

10.1 Global Markets Direct Research Methodology

10.2 Secondary Research

10.3 Primary Research

10.4 Models

10.5 Forecasts

10.6 Expert Panel Validation

10.7 Currency Conversion

10.8 Contact Us

10.9 Disclaimer

1.1 List of Tables

Table 1: Drug Delivery Devices, North America, Overall Revenue ($ mn), 2000-2015

Table 2: Drug Delivery Devices, North America, Cross-Category Analysis, 2000-2015

Table 3: Drug Delivery Devices, North America, Overall Revenue ($ mn), Historic, 2000-2008

Table 4: Drug Delivery Devices, North America, Overall Revenue ($ mn), Forecast, 2008-2015

Table 5: Drug Delivery Devices, North America, Category Volume (Units), 2000-2015

Table 6: Drug Delivery Devices, North America, Category Volume (Units), Historic, 2000-2008

Table 7: Drug Delivery Devices, North America, Category Volume (Units), Forecast, 2008-2015

Table 8: Drug Delivery Devices, North America, Company Share by Revenue ($ mn), 2007-2008

Table 9: Drug Delivery Devices, United States, Overall Revenue ($ mn), 2000-2015

Table 10: Drug Delivery Devices, United States, Overall Revenue ($ mn), Historic, 2000-2008

Table 11: Drug Delivery Devices, United States, Overall Revenue ($ mn), Forecast, 2008-2015

Table 12: Drug Delivery Devices, United States, Category Volume (Units), 2000-2015

Table 13: Drug Delivery Devices, United States, Category Volume (Units), Historic, 2000-2008

Table 14: Drug Delivery Devices, United States, Category Volume (Units), Forecast, 2008-2015

Table 15: Infusion Systems, United States, Distribution Share by Revenue ($mn), 2007-2008

Table 16: Inhalation Systems, United States, Distribution Share by Revenue ($mn), 2007-2008

Table 17: Needle Free Injections, United States, Distribution Share by Revenue ($mn), 2007-2008

Table 18: Drug Delivery Devices, United States, Company Share by Revenue ($ mn), 2007-2008

Table 19: Infusion Systems, United States, Company Share by Revenue ($ mn), 2007-2008

Table 20: Inhalation Systems, United States, Company Share by Revenue ($ mn), 2007-2008

Table 21: Needle Free Injections, United States, Company Share by Revenue ($ mn), 2007-2008

Table 22: Drug Delivery Devices, Canada, Overall Revenue ($ mn), 2000-2015

Table 23: Drug Delivery Devices, Canada, Overall Revenue ($ mn), Historic, 2000-2008

Table 24: Drug Delivery Devices, Canada, Overall Revenue ($ mn), Forecast, 2008-2015

Table 25: Drug Delivery Devices, Canada, Category Volume (Units), 2000-2015

Table 26: Drug Delivery Devices, Canada, Category Volume (Units), Historic, 2000-2008

Table 27: Drug Delivery Devices, Canada, Category Volume (Units), Forecast, 2008-2015

Table 28: Infusion Systems, Canada, Distribution Share by Revenue ($mn), 2007-2008

Table 29: Inhalation Systems, Canada, Distribution Share by Revenue ($mn), 2007-2008

Table 30: Needle Free Injections, Canada, Distribution Share by Revenue ($mn), 2007-2008

Table 31: Drug Delivery Devices, Canada, Company Share by Revenue ($ mn), 2007-2008

Table 32: Infusion Systems, Canada, Company Share by Revenue ($ mn), 2007-2008

Table 33: Inhalation Systems, Canada, Company Share by Revenue ($ mn), 2007-2008

Table 34: Needle Free Injections, Canada, Company Share by Revenue ($ mn), 2007-2008

Table 35: Terumo Corporation Pipeline Products by Equipment Type

Table 36: Terumo Corporation Pipeline Products By Development Stage

Table 37: Terumo Corporation Pipeline Products By Therapy Area

Table 38: Terumo Corporation Pipeline Products By Clinical Trials

Table 39: Terumo Corporation Pipeline Products By News Summary

Table 40: Bioject Medical Technologies Inc. Pipeline Products by Equipment Type

Table 41: Bioject Medical Technologies Inc. Pipeline Products By Development Stage

Table 42: Bioject Medical Technologies Inc. Pipeline Products By Therapy Area

Table 43: Bioject Medical Technologies Inc. Pipeline Products By Clinical Trials

Table 44: Bioject Medical Technologies Inc. Pipeline Products By News Summary

Table 45: Bespak plc Pipeline Products by Equipment Type

Table 46: Bespak plc Pipeline Products By Development Stage

Table 47: Bespak plc Pipeline Products By Therapy Area

Table 48: BBV Vietnam S.E.A. Acquisition To Merge With Migami

Table 49: Dainippon Sumitomo Pharma To Acquire Sepracor For $2.6 Billion

Table 50: Hisamitsu Pharmaceutical Completes Acquisition Of Noven Pharmaceuticals

Table 51: Teikoku Pharma USA Acquires Travanti Pharma

Table 52: Baxter International Completes Acquisition Of 40% Interest In SIGMA International General Medical Apparatus

Table 53: Endo Pharmaceuticals Acquires Indevus Pharmaceuticals

Table 54: Endo Pharmaceuticals Signs Licensing Agreement With ProStrakan Group

Table 55: BioChemics Signs An Agreement With Pacific Pharmaceutical

Table 56: Patton Medical Devices Enters Into Agreement With Unomedical

Table 57: Baxter International Enters Into A Distribution Agreement With SIGMA International

Table 58: Altea Therapeutics Enters Into An Agreement With Eli Lily And Amylin Pharmaceuticals

Table 59: FluGen Enters Into An Agreement With Ratio

Table 60: MDRNA Enters Into An Agreement With Novartis

Table 61: DSM Biomedical Enters Into An Agreement With MediVas

Table 62: USD to Local Currency, Average Exchange Rate 2008

1.2 List of Figures

Figure 1 Drug Delivery Devices, North America, Overall Revenue ($ mn), 2000-2015

Figure 2 Drug Delivery Devices, North America, Cross-Category Analysis, 2000-2015

Figure 3 Drug Delivery Devices, North America, Overall Revenue ($ mn), Historic, 2000-2008

Figure 4 Drug Delivery Devices, North America, Overall Revenue ($ mn), Forecast, 2008-2015

Figure 5 Drug Delivery Devices, North America, Category Volume (Units), 2000-2015

Figure 6 Drug Delivery Devices, North America, Category Volume (Units), Historic, 2000-2008

Figure 7 Drug Delivery Devices, North America, Category Volume (Units), Forecast, 2008-2015

Figure 8 Drug Delivery Devices, North America, Company Share (%), 2008

Figure 9 Drug Delivery Devices, United States, Overall Revenue ($ mn), 2000-2015

Figure 10 Drug Delivery Devices, United States, Overall Revenue ($ mn), Historic, 2000-2008

Figure 11 Drug Delivery Devices, United States, Overall Revenue ($ mn), Forecast, 2008-2015

Figure 12 Drug Delivery Devices, United States, Category Volume (Units), 2000-2015

Figure 13 Drug Delivery Devices, United States, Category Volume (Units), Historic, 2000-2008

Figure 14 Drug Delivery Devices, United States, Category Volume (Units), Forecast, 2008-2015

Figure 15 Drug Delivery Devices, United States, Company Share (%), 2008

Figure 16 Infusion Systems, United States, Company Share (%), 2008

Figure 17 Inhalation Systems, United States, Company Share (%), 2008

Figure 18 Needle Free Injections, United States, Company Share (%), 2008

Figure 19 Drug Delivery Devices, Canada, Overall Revenue ($ mn), 2000-2015

Figure 20 Drug Delivery Devices, Canada, Overall Revenue ($ mn), Historic, 2000-2008

Figure 21 Drug Delivery Devices, Canada, Overall Revenue ($ mn), Forecast, 2008-2015

Figure 22 Drug Delivery Devices, Canada, Category Volume (Units), 2000-2015

Figure 23 Drug Delivery Devices, Canada, Category Volume (Units), Historic, 2000-2008

Figure 24 Drug Delivery Devices, Canada, Category Volume (Units), Forecast, 2008-2015

Figure 25 Drug Delivery Devices, Canada, Company Share (%), 2008

Figure 26 Infusion Systems, Canada, Company Share (%), 2008

Figure 27 Inhalation Systems, Canada, Company Share (%), 2008

Figure 28 Needle Free Injections, Canada, Company Share (%), 2008

Figure 29 Global Markets Direct Methodology

Abstract

• The report provides information on the drug delivery devices market in North America.
• Details on the key segments and categories such as Inhalation Systems, Needle Free Injections, and Infusion Systems.
• Total revenues, products sold and end users.
• Market shares of all the key competitors such as AstraZeneca International plc, Sepracor Inc., Novartis AG, GlaxoSmithKline plc, and Cardinal Health, Inc.
• Key pipeline products that are set to shape the market, broken down by sector.
• Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
• Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
• Key mergers and acquisitions, partnerships, private equity investments and IPOs.
• Customer, hospitals and physicians data.

• Gain a strong understanding of the drug delivery devices market in North America.
• Evaluate and compare the attractiveness of the market in the region.
• Identify growth segments and opportunities in each industry sector within the region.
• Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the region.
• Analyze the competitiveness of the market in the region and identify hotspots.
• Develop strategies based on the latest product, brand, expansion and research and development news in the region.
• Plan deal strategies with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the region.
• Identify and analyze the strengths and weaknesses of the industry incumbents in the region.

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 250,000 market research reports, company profiles and country profiles from over 650 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.